Naldemedine
ATC A06AH05 · 6 markets · 6 records
US 1 records · 1 strengths
- 0.2 mgtabletSYMPROIC
GB 1 records · 1 strengths
Records without a stated strength · 1 Rizmoic 200microgram tablets
ES 1 records · 1 strengths
- 0.2 mgtabletRIZMOIC
TW 1 records · 1 strengths
- 0.2 mgtabletSYMPROIC適秘效膜衣錠0.2毫克
HK 1 records · 1 strengths
Records without a stated strength · 1 SYMPROIC
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 RIZMOIC
| Strength / form / release | US | GB | ES | TW | HK | EU |
|---|---|---|---|---|---|---|
| 0.2 mgRecorded as: 200 mcg tablet | SYMPROIC | RIZMOIC | SYMPROIC 適秘效膜衣錠0.2毫克 | |||
unknown | SYMPROIC | RIZMOIC | ||||
tablet | Rizmoic 200microgram tablets |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in GB · HK · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en GB · HK · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 GB · HK · EU 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 GB · HK · EU 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.